This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Abacus Life, Inc. (ABL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Abacus Life, Inc. (ABL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Hartford Beat Q2 Earnings Estimates on Growing Premiums?
by Zacks Equity Research
HIG eyes another earnings beat, fueled by premium growth and stronger Personal Insurance results in the second quarter.
Will Abacus Life, Inc. (ABL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Abacus Life, Inc. (ABL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Abacus Life, Inc. (ABL) Upgraded to Buy: Here's Why
by Zacks Equity Research
Abacus Life, Inc. (ABL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Predict a 57.47% Upside in Abacus Life, Inc. (ABL): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 57.5% upside potential for Abacus Life, Inc. (ABL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Is Abacus Life, Inc. (ABL) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Abacus Life, Inc. (ABL) and Annaly Capital Management (NLY) have performed compared to their sector so far this year.
Abacus Life, Inc. (ABL) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Abacus Life, Inc. (ABL) delivered earnings and revenue surprises of 12.50% and 11.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Abacus Life, Inc. (ABL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Abacus Life, Inc. (ABL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Abacus Life Stock?
by Zacks Equity Research
Investors need to pay close attention to ABL stock based on the movements in the options market lately.
Abacus Life, Inc. (ABL) Soars 6.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Abacus Life, Inc. (ABL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Wall Street Analysts See a 76.37% Upside in Abacus Life, Inc. (ABL): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Abacus Life, Inc. (ABL) points to a 76.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks Industry Outlook Highlights Aviva, NN Group, Jackson Financial and Abacus Global Management
by Zacks Equity Research
Aviva, NN Group, Jackson Financial and Abacus Global Management are part of the Zacks Industry Outlook article.
4 Stocks to Watch From a Prospering Life Insurance Industry
by Tanuka De
Redesigning and repricing of products and services amid a low rate environment are likely to help Zacks Life Insurance industry players like AVVIY, NNGRY, JXN and ABL. These companies are investing heavily in digitization.
Abacus Life, Inc. (ABL) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Abacus Life, Inc. (ABL) delivered earnings and revenue surprises of 23.08% and 15.67%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
MFC Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Manulife Financial stock rallies on the back of solid Asia business, expanding Wealth and Asset Management business and strong capital position.
Citizens (CIA) Q4 Earnings Miss Estimates
by Zacks Equity Research
Citizens (CIA) delivered earnings and revenue surprises of -30% and 3.67%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
VersaBank (VBNK) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
VersaBank (VBNK) delivered earnings and revenue surprises of -31.03% and 8.98%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
GoHealth (GOCO) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
GoHealth (GOCO) delivered earnings and revenue surprises of 107.76% and 21.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
The Baldwin Insurance Group (BWIN) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
The Baldwin Insurance Group (BWIN) delivered earnings and revenue surprises of 8% and 0.71%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Abacus Life (ABL) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Abacus Life (ABL) stock based on the movements in the options market lately.
Abacus Life, Inc. (ABL) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Abacus Life, Inc. (ABL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Think Abacus Life, Inc. (ABL) Could Surge 86.27%: Read This Before Placing a Bet
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 86.3% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Willis Towers Stock Rises 28.3% in a Year: Will the Rally Last?
by Zacks Equity Research
WTW is poised to grow on strong new business, strategic acquisitions, geographic diversification, solid customer retention levels and strong capital position.
Reinsurance Group Stock Rises 41.6% YTD: Will the Rally Last?
by Zacks Equity Research
New business volumes, favorable longevity experience, a diversified business, effective capital deployment and higher return on capital poise RGA for growth.
Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 59.48%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 59.5% in Abacus Life, Inc. (ABL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.